We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

68 hedge funds and large institutions have $198M invested in TriSalus Life Sciences in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

3% more funds holding

Funds holding: 66 → 68 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less ownership

Funds ownership: 81.46% → 80.46% (-1%)

2% less capital invested

Capital invested by funds: $202M → $198M (-$3.98M)

56% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 18

Holders
68
Holders Change
+2
Holders Change %
+3.03%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
8
Reduced
18
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Weiss Asset Management
Massachusetts
+$9.32M
2
WCMNY
Westchester Capital Management (New York)
New York
+$5.12M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$2.14M
4
Nomura Holdings
Nomura Holdings
Japan
+$322K
5
AA
AlphaCentric Advisors
Puerto Rico
+$248K

Top Sellers

Rank Fund Capital Flow
1
IM
Islet Management
New York
-$4.88M
2
PAMP
Polar Asset Management Partners
Ontario, Canada
-$3.9M
3
HSBC Holdings
HSBC Holdings
United Kingdom
-$2.33M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.13M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
26
Point72 Asset Management
Connecticut
$1.98M – – –
AGC
27
Angelo Gordon & Co
New York
$1.8M – – –
Millennium Management
28
Millennium Management
New York
$1.73M -$112K -11,250 -6%
CCM
29
Context Capital Management
California
$1.72M – – –
Goldman Sachs
30
Goldman Sachs
New York
$1.34M – – –
RL
31
RPO LLC
Connecticut
$1.32M +$1.33M +133,984 New
FTCM
32
Fir Tree Capital Management
New York
$1.24M – – –
AA
33
AQR Arbitrage
Connecticut
$1.21M – – –
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$1.17M – – –
LCM
35
Landscape Capital Management
New Jersey
$1.13M -$319K -32,145 -22%
PC
36
Periscope Capital
Ontario, Canada
$1.05M -$6.25K -629 -0.6%
Nomura Holdings
37
Nomura Holdings
Japan
$1.03M +$322K +32,400 +45%
ZDA
38
Zweig-DiMenna Associates
New York
$889K – – –
Jane Street
39
Jane Street
New York
$886K +$715 +72 +0.1%
IPCP
40
Iron Park Capital Partners
New York
$545K +$548K +55,117 New
JP Morgan Chase
41
JP Morgan Chase
New York
$543K -$1.94M -195,210 -78%
CM
42
Crestline Management
Texas
$532K – – –
WA
43
Whitebox Advisors
Minnesota
$520K -$31.8K -3,200 -6%
COPPSERS
44
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$494K – – –
SCM
45
Segantii Capital Management
Hong Kong
$494K – – –
TIM
46
Timelo Investment Management
Ontario, Canada
$494K +$497K +50,000 New
Verition Fund Management
47
Verition Fund Management
Connecticut
$417K – – –
OCAM
48
Owl Creek Asset Management
New York
$395K – – –
KJHP
49
K.J. Harrison & Partners
Ontario, Canada
$346K -$447K -45,000 -56%
SSA
50
Schonfeld Strategic Advisors
New York
$339K -$206K -20,731 -38%
1
2
3 4

TLSI Hedge Fund Activity: Q4 2021 in Review

68 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q4 2021, worth a combined $198M — down 2% from $202M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TLSI positions and 8 closed out — a net gain of 3 holders — while 8 added to existing stakes and 18 trimmed.

The largest buyer was Weiss Asset Management, adding an estimated $9.32M. The largest seller was Islet Management, exiting entirely with an estimated $4.88M sold.

  • 68 institutional investors held TriSalus Life Sciences (TLSI) as of Q4 2021, up from 66 in Q3 2021.
  • Funds reported $198M of TriSalus Life Sciences stock for Q4 2021, down 2% quarter-over-quarter.
  • 11 funds opened new TriSalus Life Sciences positions in Q4 2021 and 8 closed out, a net change of +3 holders.
  • The largest TriSalus Life Sciences buyer in Q4 2021 was Weiss Asset Management, an estimated $9.32M added.
  • The largest TriSalus Life Sciences seller in Q4 2021 was Islet Management, an estimated $4.88M sold.

Based on aggregated 13F filings for Q4 2021.